Table 2 Cumulative incidence of severe sepsis in cirrhotic patients admitted to intensive-care units between 2005 and 2010
From: Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit
Control-group | CHC-group | p-value | |
|---|---|---|---|
Severe sepsis | 1511 (36.6 %) | 431 (37.9 %) | 0.456 |
Acute organ dysfunction | |||
Respiratory | 1329 (88 %) | 365 (84.7 %) | 0.963 |
Cardiovascular | 1018 (67.4 %) | 283 (65.7 %) | 0.920 |
Renal | 1036 (68.6 %) | 288 (66.8 %) | 0.919 |
Hematological | 469 (31 %) | 124 (28.8 %) | 0.697 |
Metabolic | 254 (16.8 %) | 84 (19.5 %) | 0.154 |
Neurological | 222 (14.7 %) | 43 (10 %) | 0.035 |
Hepatic | 556 (36.8 %) | 146 (33.9 %) | 0.606 |
Site of infection | |||
Respiratory | 515 (34.1 %) | 157 (36.4 %) | 0.259 |
Digestive | 896 (59.3 %) | 267 (61.9 %) | 0.222 |
Genitourinary | 171 (11.3 %) | 46 (10.7 %) | 0.946 |
Central nervous system | 16 (1.1 %) | 9 (2.1 %) | 0.132 |
Skin, soft tissue, or bone | 87 (5.8 %) | 33 (7.7 %) | 0.141 |
Circulatory | 39 (2.6 %) | 8 (1.9 %) | 0.555 |